These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36515045)

  • 41. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
    Rath SK; Singh S; Kumar S; Wani NA; Rai R; Koul S; Khan IA; Sangwan PL
    Bioorg Med Chem; 2019 Jan; 27(2):343-353. PubMed ID: 30552006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes.
    Huet AA; Raygada JL; Mendiratta K; Seo SM; Kaatz GW
    Microbiology (Reading); 2008 Oct; 154(Pt 10):3144-3153. PubMed ID: 18832320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Major Facilitator Superfamily (MFS) Efflux Pump, SCO4121, from Streptomyces coelicolor with Roles in Multidrug Resistance and Oxidative Stress Tolerance and Its Regulation by a MarR Regulator.
    Nag A; Mehra S
    Appl Environ Microbiol; 2021 Mar; 87(7):. PubMed ID: 33483304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Staphylococcus aureus Efflux Pumps and Tolerance to Ciprofloxacin and Chlorhexidine following Induction by Mupirocin.
    Truong-Bolduc QC; Wang Y; Reedy JL; Vyas JM; Hooper DC
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0184521. PubMed ID: 34930023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles of Efflux Pumps from Different Superfamilies in the Surface-Associated Motility and Virulence of
    Pérez-Varela M; Corral J; Aranda J; Barbé J
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defying Multidrug Resistance! Modulation of Related Transporters by Flavonoids and Flavonolignans.
    Chambers CS; Viktorová J; Řehořová K; Biedermann D; Turková L; Macek T; Křen V; Valentová K
    J Agric Food Chem; 2020 Feb; 68(7):1763-1779. PubMed ID: 30907588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
    Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E
    J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps.
    Pieroni M; Dimovska M; Brincat JP; Sabatini S; Carosati E; Massari S; Kaatz GW; Fravolini A
    J Med Chem; 2010 Jun; 53(11):4466-80. PubMed ID: 20446747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and evaluation of PSSRI-based inhibitors of Staphylococcus aureus multidrug efflux pumps.
    German N; Kaatz GW; Kerns RJ
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1368-73. PubMed ID: 18242086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural basis for inhibition of the drug efflux pump NorA from Staphylococcus aureus.
    Brawley DN; Sauer DB; Li J; Zheng X; Koide A; Jedhe GS; Suwatthee T; Song J; Liu Z; Arora PS; Koide S; Torres VJ; Wang DN; Traaseth NJ
    Nat Chem Biol; 2022 Jul; 18(7):706-712. PubMed ID: 35361990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the antibacterial and inhibitory activity of NorA and MepA efflux pumps from Staphylococcus aureus by diosgenin.
    do Socorro Costa M; da Silva ARP; Araújo NJS; Filho JMB; Tavares JF; de Freitas TS; Pereira Junior FN; de Sousa EO; Maia FPA; de Vasconcelos JEL; Pinheiro JCA; Coutinho HDM
    Life Sci; 2022 Nov; 308():120978. PubMed ID: 36122765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus.
    Handzlik J; Matys A; Kieć-Kononowicz K
    Antibiotics (Basel); 2013 Feb; 2(1):28-45. PubMed ID: 27029290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of an Antibiotic Resistance Breaker to Resensitize Drug-Resistant
    Thamilselvan G; Sarveswari HB; Vasudevan S; Stanley A; Shanmugam K; Vairaprakash P; Solomon AP
    Front Cell Infect Microbiol; 2021; 11():700198. PubMed ID: 34485178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Update on
    Monteiro KLC; de Aquino TM; Mendonça Junior FJB
    Curr Top Med Chem; 2020; 20(24):2168-2185. PubMed ID: 32621719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efflux pump inhibitors of clinically relevant multidrug resistant bacteria.
    Lamut A; Peterlin Mašič L; Kikelj D; Tomašič T
    Med Res Rev; 2019 Nov; 39(6):2460-2504. PubMed ID: 31004360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chalcones Isolated from
    Rezende-Júnior LM; Andrade LMS; Leal ALAB; Mesquita ABS; Santos ALPAD; Neto JSL; Siqueira-Júnior JP; Nogueira CES; Kaatz GW; Coutinho HDM; Martins N; da Rocha CQ; Barreto HM
    Antibiotics (Basel); 2020 Jun; 9(6):. PubMed ID: 32575738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergence of a Plasmid-Encoded Resistance-Nodulation-Division Efflux Pump Conferring Resistance to Multiple Drugs, Including Tigecycline, in Klebsiella pneumoniae.
    Lv L; Wan M; Wang C; Gao X; Yang Q; Partridge SR; Wang Y; Zong Z; Doi Y; Shen J; Jia P; Song Q; Zhang Q; Yang J; Huang X; Wang M; Liu JH
    mBio; 2020 Mar; 11(2):. PubMed ID: 32127452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates.
    Balganesh M; Dinesh N; Sharma S; Kuruppath S; Nair AV; Sharma U
    Antimicrob Agents Chemother; 2012 May; 56(5):2643-51. PubMed ID: 22314527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functionally cloned pdrM from Streptococcus pneumoniae encodes a Na(+) coupled multidrug efflux pump.
    Hashimoto K; Ogawa W; Nishioka T; Tsuchiya T; Kuroda T
    PLoS One; 2013; 8(3):e59525. PubMed ID: 23555691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.